These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 2537729

  • 1. Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer.
    Jørgensen LG, Hansen HH, Cooper EH.
    Eur J Cancer Clin Oncol; 1989 Jan; 25(1):123-8. PubMed ID: 2537729
    [Abstract] [Full Text] [Related]

  • 2. Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma.
    Fizazi K, Cojean I, Pignon JP, Rixe O, Gatineau M, Hadef S, Arriagada R, Baldeyrou P, Comoy E, Le Chevalier T.
    Cancer; 1998 Mar 15; 82(6):1049-55. PubMed ID: 9506348
    [Abstract] [Full Text] [Related]

  • 3. [Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)].
    Kawahara M, Furuse K, Arai R, Tsuruta M, Kodama N, Hayashi S, Kiyota M, Kubota K, Mori T, Yamamoto S.
    Gan To Kagaku Ryoho; 1987 Jan 15; 14(1):146-51. PubMed ID: 3026253
    [Abstract] [Full Text] [Related]

  • 4. Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
    van Zandwijk N, Jassem E, Bonfrer JM, Mooi WJ, van Tinteren H.
    Semin Oncol; 1992 Feb 15; 19(1 Suppl 2):37-43. PubMed ID: 1329221
    [Abstract] [Full Text] [Related]

  • 5. Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
    Jørgensen LG, Osterlind K, Hansen HH, Cooper EH.
    Br J Cancer; 1994 Oct 15; 70(4):759-61. PubMed ID: 7917935
    [Abstract] [Full Text] [Related]

  • 6. The prognostic influence of serum neuron specific enolase in small cell lung cancer.
    Jørgensen LG, Osterlind K, Hansen HH, Cooper EH.
    Br J Cancer; 1988 Dec 15; 58(6):805-7. PubMed ID: 2852029
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer.
    Akoun GM, Scarna HM, Milleron BJ, Bénichou MP, Herman DP.
    Chest; 1985 Jan 15; 87(1):39-43. PubMed ID: 2981171
    [Abstract] [Full Text] [Related]

  • 9. Serum neuron-specific enolase as a tumor marker in the diagnosis and follow-up of small-cell lung cancer.
    Pinson P, Joos G, Watripont P, Brusselle G, Pauwels R.
    Respiration; 1997 Jan 15; 64(1):102-7. PubMed ID: 9044484
    [Abstract] [Full Text] [Related]

  • 10. Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen.
    Niho S, Nishiwaki Y, Goto K, Ohmatsu H, Matsumoto T, Hojo F, Ohe Y, Kakinuma R, Kodama T.
    Lung Cancer; 2000 Mar 15; 27(3):159-67. PubMed ID: 10699689
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer.
    Burghuber OC, Worofka B, Schernthaner G, Vetter N, Neumann M, Dudczak R, Kuzmits R.
    Cancer; 1990 Mar 15; 65(6):1386-90. PubMed ID: 2155054
    [Abstract] [Full Text] [Related]

  • 14. Comparison of Tc-99m sestamibi, serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy in small cell lung cancer.
    Lim SC, Park KO, Kim YC, Na KJ, Song H, Bom HS.
    Cancer Biother Radiopharm; 2000 Aug 15; 15(4):381-6. PubMed ID: 11041023
    [Abstract] [Full Text] [Related]

  • 15. [The changes in serum neuron-specific enolase in patients with small cell lung cancer].
    Taitou H, Sakurai M, Tamura T, Sasaki Y, Eguchi K, Shinkai T, Ookura H, Saijo N.
    Gan To Kagaku Ryoho; 1987 Nov 15; 14(11):3046-9. PubMed ID: 2823722
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres.
    Jørgensen LG, Osterlind K, Genollá J, Gomm SA, Hernández JR, Johnson PW, Løber J, Splinter TA, Szturmowicz M.
    Br J Cancer; 1996 Aug 15; 74(3):463-7. PubMed ID: 8695366
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer.
    Cooper EH, Splinter TA, Brown DA, Muers MF, Peake MD, Pearson SL.
    Br J Cancer; 1985 Sep 15; 52(3):333-8. PubMed ID: 2994704
    [Abstract] [Full Text] [Related]

  • 19. The significance of NSE and CEA as a differentiation marker for the cellular heterogeneity of small cell lung cancer.
    Kobayashi S, Okada S, Hasumi T, Sato N, Fujimura S.
    Tohoku J Exp Med; 1999 Sep 15; 189(1):37-49. PubMed ID: 10622207
    [Abstract] [Full Text] [Related]

  • 20. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer].
    Fukuoka M, Takada M, Kamei T, Negoro S, Kusunoki Y, Matsui K, Ryu S, Sakai N, Takifuji N, Masuda N.
    Gan To Kagaku Ryoho; 1987 Mar 15; 14(3 Pt 2):871-80. PubMed ID: 3032108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.